Russian billionaire Dmitry Rybolovlev largely lost a legal fight over whether his family trust was on the hook to provide tens of millions of dollars to a US venture capital firm to finance life-science startups.
Action Potential Venture Capital invests in bioelectronic medicines, which treat diseases with electrical pulses instead of drugs. Photo courtesy of GSK UK pharmaceutical company GSK […]
RIYADH: Saudi Arabia’s business landscape is set to see a “record year of liquidity events” in 2026, Philip Bahoshy, CEO of venture data platform MAGNiTT, […]
Niti Aayog member and former DRDO director general VK Saraswat on Sunday said venture capitalists must increase financial support for Indian defence startups, asserting that […]